710348-89-3 Usage
Uses
Used in Pharmaceutical Industry:
8-FLUORO-10,11-DIHYDRO-BENZO[4,5]CYCLOHEPTA[1,2-B]PYRIDIN-5-ONE is used as a research compound for the development of novel antidepressant and anxiolytic medications. Its unique structure and fluorination may offer distinct pharmacological profiles compared to existing treatments, potentially leading to more effective or safer options for patients suffering from depression and anxiety disorders.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 8-FLUORO-10,11-DIHYDRO-BENZO[4,5]CYCLOHEPTA[1,2-B]PYRIDIN-5-ONE serves as a key molecule for studying the structure-activity relationships of tricyclic antidepressants. Its synthesis and modification can provide insights into the design of new drugs with improved efficacy and reduced side effects.
Used in Drug Development for Neurological Disorders:
8-FLUORO-10,11-DIHYDRO-BENZO[4,5]CYCLOHEPTA[1,2-B]PYRIDIN-5-ONE is utilized in the search for new therapeutic agents targeting neurological disorders. Given its potential to modulate neurotransmitter systems implicated in mood regulation and stress response, 8-FLUORO-10,11-DIHYDRO-BENZO[4,5]CYCLOHEPTA[1,2-B]PYRIDIN-5-ONE may contribute to the advancement of treatments for a range of conditions, including but not limited to major depressive disorder, generalized anxiety disorder, and other stress-related disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 710348-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,0,3,4 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 710348-89:
(8*7)+(7*1)+(6*0)+(5*3)+(4*4)+(3*8)+(2*8)+(1*9)=143
143 % 10 = 3
So 710348-89-3 is a valid CAS Registry Number.
710348-89-3Relevant academic research and scientific papers
TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
-
Page 311, (2008/06/13)
The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula (I): or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula (I), including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula (I).
